Skip to main content

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que confieren resistencia al estrés celular.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que , Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI14/01320
Duration: 01/01/2015 - 31/03/2018

Intensificació

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT13/00308
Duration: 26/06/2014 - 25/06/2014

Plataforma de biobancs

IP: Isabel Novoa Garcia
Collaborators: Santiago Ramon y Cajal Agüeras, Miriam Gonzalez Amores, Sheyla Pascual Martín
Funding agency: Instituto de Salud Carlos III
Funding: 295623.9
Reference: PT13/0010/0021
Duration: 01/01/2014 - 31/12/2018

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Maria Eugenia Palacio Lacambra

Maria Eugenia Palacio Lacambra

Postdoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Mariona Morell Daniel

Mariona Morell Daniel

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Cecilia González Santesteban

Cecilia González Santesteban

Postdoctoral researcher
Transfusional Medicine
Read more
Sofia Rodriguez Fernandez

Sofia Rodriguez Fernandez

Research technician
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.